当前位置:首页 >英文主页 >中英对照 > 中译版报告详情

艾意凯咨询:2023年医疗通信趋势报告-外包的影响与转型(中译版)(21页).pdf

上传人: 白**** 编号:131645 2023-07-06 21页 1.26MB

下载:

1、SPECIAL REPORTMedical Communications Trends:Outsourcing Implications and Transformation2 L.E.K.ConsultingAbout L.E.K.ConsultingWere L.E.K.Consulting,a global strategy consultancy working with business leaders to seize competitive advantage and amplify growth.Our insights are catalysts that reshape t

2、he trajectory of our clients businesses,uncovering opportunities and empowering them to master their moments of truth.Since 1983,our worldwide practice spanning the Americas,Asia Pacific and Europe has guided leaders across all industries from global corporations to emerging entrepreneurial business

3、es and private equity investors.Looking for more?Visit .L.E.K.Consulting is a registered trademark of L.E.K.Consulting LLC.All other products and brands mentioned in this document are properties of their respective owners.2023 L.E.K.Consulting LLCSPECIAL REPORTContentsIntroduction.3The importance of

4、 medical communications within an evolving market.4Key trends within medical communications.6Biopharma companies are increasing their investment in medical communications.7Biopharma companies will also increasingly leverage the expertise of medical communications service providers.8Service provider

5、selection criteria are evolving,including a greater focus on digital and quant abilities.9 Within digital,biopharma companies cite unmet needs around content personalization,KPIs,review processes and data capture.11The importance and applicability of HEOR will continue to grow.11Winning strategies f

6、or medical communications service providers.13 Considerations for other types of service providers.18Summary.193 L.E.K.ConsultingSPECIAL REPORTIntroductionThe need for a biopharmaceutical company to articulate a products value to physicians,payers and patients is more complex than ever.More products

word格式文档无特别注明外均可编辑修改,预览文件经过压缩,下载原文更清晰!
三个皮匠报告文库所有资源均是客户上传分享,仅供网友学习交流,未经上传用户书面授权,请勿作商用。
本文主要讨论了医疗通信领域的关键趋势及其对服务提供商的影响。主要内容包括: 1. 生物制药公司正在增加对医疗通信的投资,预计未来三年内,对典型产品的投资将显著增加。 2. 生物制药公司越来越多地利用医疗通信服务提供商的专长,预计未来三年内,外包给外部服务提供商的支出比例将增加。 3. 在数字领域,生物制药公司对内容个性化、KPI、审查流程和数据捕获等方面存在未满足的需求。 4. 健康经济学和结果研究(HEOR)的重要性将继续增长。 5. 服务提供商的选择标准正在演变,包括对数字和定量能力的更大关注。 6. 生物制药公司对服务提供商的购买标准因功能而异,但数字营销专业知识、数据生成的质量、科学领导力和客户服务等因素普遍受到重视。 7. 未来,数字营销/通信专业知识的重要性预计将在所有三个功能中增加。
生物制药公司如何增加对医疗交流的投资? 医疗交流服务提供商如何利用数字和量化能力脱颖而出? 医疗交流中健康经济学和结果研究的重要性如何持续增长?
客服
商务合作
小程序
服务号
折叠